Ven Bio Partners LLC Alx Oncology Holdings Inc Transaction History
Ven Bio Partners LLC
- $122 Million
- Q4 2024
A detailed history of Ven Bio Partners LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Ven Bio Partners LLC holds 9,699,925 shares of ALXO stock, worth $8.05 Million. This represents 13.33% of its overall portfolio holdings.
Number of Shares
9,699,925
Previous 9,699,925
-0.0%
Holding current value
$8.05 Million
Previous $17.7 Million
8.24%
% of portfolio
13.33%
Previous 14.51%
Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Redmile Group, LLC San Francisco, CA3.69MShares$3.06 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$2.74 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.23 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.07 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.13MShares$1.77 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $33.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...